FindTrial
Sign In

Treatment of early femoral head necrosis with minimally invasive decompression combined with platelet-rich plasma (PRP) to reverse osteonecrosis

Treatment of early femoral head necrosis with minimally invasive decompression combined with platelet-rich plasma (PRP) to reverse osteonecrosis

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000037854
Enrollment
Unknown
Registered
2020-09-02
Start date
2020-10-01
Completion date
Unknown
Last updated
2020-11-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Necrosis of femoral head

Interventions

ARCO stage 1 -Group A:minimally invasive decompression
ARCO stage 1- Group B:minimally invasive decompression combined with PRP
ARCO stage 2-Group A:minimally invasive decompression
ARCO stage 2-Group B:minimally invasive decompression combined with PRP

Sponsors

Shanghai 10th People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Patients aged 18-50 years old; 2. Patients with avascular necrosis of the femoral head diagnosed by MRI; 3. 20 patients with Arco stage 1 and stage 2.

Exclusion criteria

Exclusion criteria: 1. Patients who have received the treatment of other research drugs in the last 30 days; 2. There is virus activity infection and the research leader thinks that it will reduce the patient's tolerance; 3. Subjects in pregnancy or lactation period; 4. Patients with severe complications; 5. Patients with serious heart disease, such as history of congestive heart failure, arrhythmia, angina pectoris, etc.

Design outcomes

Primary

MeasureTime frame
Effectiveness;Adverse events;—

Countries

China

Contacts

Public ContactPan Jianfeng

Shanghai 10th People's Hospital

pansmith@163.com+86 15900931197

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026